Characterization of the Serratia marcescens SdeCDE multidrug efflux pump studied via gene knockout mutagenesis

Canadian Journal of Microbiology

Volumn 54, Issue 5, 2008, Pages 411-416

  Begic, Sanela ^a   Worobec, Elizabeth A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Antibiotic resistance; Efflux pumps; Serratia marcescens

Indexed keywords

ANTIBIOTICS; CELLS; GENETIC ENGINEERING; MUTAGENESIS;

ANTIBIOTIC RESISTANCE; GENE DELETION MUTANTS; SERRATIA MARCESCENS;

BACTERIA;

BACTERIAL PROTEIN; CARRIER PROTEIN; NOVOBIOCIN; PROTEIN SDECDE;

ANTIBIOTIC RESISTANCE; BACTERIUM; COMPARATIVE STUDY; GENE; MUTATION; NODULATION;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CELL DIVISION; DELETION MUTANT; HOSPITAL INFECTION; KNOCKOUT GENE; MUTAGENESIS; NODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SERRATIA MARCESCENS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENETIC COMPLEMENTATION TEST; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS; SEQUENCE DELETION; SERRATIA INFECTIONS; SERRATIA MARCESCENS;

SERRATIA MARCESCENS;

EID: 43949103042     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/W08-019     Document Type: Article

References (17)

1. Baranova, N., and Nikaido, H. 2002. The BaeSR two-component regulatory system activates transcription of the yegMNOB (mdtABCD) transporter gene cluster in Escherichia coli and increases its resistance to novobiocin and deoxycholate. J. Bacteriol. 184: 4168-4176. doi:10.1128/JB.184.15. 4168-4176.2002. PMID:12107134.
2. Begic, S., and Worobec, E.A. 2008. The role of Serratia marcescens SdeAB multidrug efflux pump and TolC-homolog in fluoroquinolone resistance studied via gene knockout mutagenesis. Microbiology (Read.) 154: 454-461. doi:10.1099/mic.0.2007/012427-0.
3. Chen, J., Kuroda, T., Huda, M.N., Mizushima, T., and Tsuchiya, T. 2003. An RND-type multidrug efflux pump SdeXY from Serratia marcescens. J. Antimicrob. Chemother. 52: 176-179. doi:10.1093/jac/dkg308. PMID:12837741.
4. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing. Supplement M100-S16. Clinical and Laboratory Standards Institute, Wayne, Penn.
5. Finan, T.M., Kunkel, B., De Vos, G., and Signer, E.R.F. 1986. Second symbiotic megaplasmid in Rhizobium meliloti carrying exopolysaccharide and thiamine synthesis genes. J. Bacteriol. 167: 66-72. PMID:3013840.
6. Fujimaki, K., Fujii, T., Aoyama, H., Sato, K.-Y., Inoue, Y., Inoue, M., and Mitsuhashi, S. 1989. Quinolone resistance in clinical isolates of Serratia marcescens. Antimicrob. Agents Chemother. 33: 785-787. PMID:2546493.
7. Giraud, E., Cloeckaert, A., Kerboeuf, D., and Chaslus-Dancla, E. 2000. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 44: 1223-1228. doi:10.1128/AAC.44.5.1223-1228.2000. PMID:10770755.
8. Kaniga, K., Delor, I., and Cornelis, G.R. 1991. A wide-host-range suicide vector for improving reverse genetics in Gram-negative bacteria: inactivation of the blaA gene of Yersinia enterocolitica. Gene, 109: 137-141. doi:10.1016/0378-1119(91)90599-7. PMID:1756974.
9. Kumar, A., and Worobec, E.A. 2005a. HasF, a TolC-homolog of Serratia marcescens, is involved in energy-dependent efflux. Can. J. Microbiol. 51: 497-500. doi:10.1139/w05-029. PMID: 16121228.
10. Kumar, A., and Worobec, E.A. 2005b. Cloning, sequencing and characterization of the SdeAB multidrug efflux pump of Serratia marcescens. Antimicrob. Agents Chemother. 49: 1495-1501. doi:10.1128/AAC.49.4.1495-1501.2005. PMID:15793131.
11. Li, X.-Z., and Nikaido, H. 2004. Efflux-mediated drug resistance in bacteria. Drugs, 64: 159-204. doi:10.2165/00003495-200464020-00004. PMID:14717618.
12. Ma, D., Cook, D.N., Alberti, M., Pon, N.G., Nikaido, H., and Hearst, J.E. 1995. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol. Microbiol. 16: 45-55. doi:10.1111/j.1365-2958.1995.tb02390.x. PMID:7651136.
13. Maxwell, A., and Lawson, D.M. 2003. The ATP-binding site of type II topoisomerases as a target for antibacterial drugs. Curr. Top. Med. Chem. 3: 283-303. doi:10.2174/1568026033452500. PMID:12570764.
14. Mortimer, P.G., and Piddock, L.J. 1991. A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J. Antimicrob. Chemother. 28: 639-653. doi:10.1093/jac/28.5.639. PMID:1663928.
15. Nagakubo, S., Nishino, K., Hirata, T., and Yamaguchi, A. 2002. The putative response regulator BaeR stimulates multidrug resistance of Escherichia coli via a novel multidrug exporter system, MdtABC. J. Bacteriol. 184: 4161-4167. doi:10.1128/JB.184.15.4161-4167.2002. PMID:12107133.
16. Pearson, J.P., Pesci, E.C., and Iglewski, B.H. 1997. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes. J. Bacteriol. 179: 5756-5757. PMID:9294432.
17. Poole, K., Krebes, K., McNally, C., and Neshat, S. 1993. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175: 7363-7372. PMID:8226684.